18-57580222-G-A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_000140.5(FECH):​c.68-23C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.202 in 1,613,044 control chromosomes in the GnomAD database, including 38,415 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.27 ( 6866 hom., cov: 32)
Exomes 𝑓: 0.19 ( 31549 hom. )

Consequence

FECH
NM_000140.5 intron

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:8

Conservation

PhyloP100: 0.509

Publications

13 publications found
Variant links:
Genes affected
FECH (HGNC:3647): (ferrochelatase) The protein encoded by this gene is localized to the mitochondrion, where it catalyzes the insertion of the ferrous form of iron into protoporphyrin IX in the heme synthesis pathway. Mutations in this gene are associated with erythropoietic protoporphyria. Two transcript variants encoding different isoforms have been found for this gene. A pseudogene of this gene is found on chromosome 3.[provided by RefSeq, May 2010]
FECH Gene-Disease associations (from GenCC):
  • protoporphyria, erythropoietic, 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae)
  • autosomal erythropoietic protoporphyria
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 18-57580222-G-A is Benign according to our data. Variant chr18-57580222-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 550.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.442 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FECHNM_000140.5 linkc.68-23C>T intron_variant Intron 1 of 10 ENST00000262093.11 NP_000131.2 P22830-1Q7KZA3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FECHENST00000262093.11 linkc.68-23C>T intron_variant Intron 1 of 10 1 NM_000140.5 ENSP00000262093.6 P22830-1

Frequencies

GnomAD3 genomes
AF:
0.274
AC:
41599
AN:
151926
Hom.:
6851
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.447
Gnomad AMI
AF:
0.0822
Gnomad AMR
AF:
0.302
Gnomad ASJ
AF:
0.215
Gnomad EAS
AF:
0.324
Gnomad SAS
AF:
0.251
Gnomad FIN
AF:
0.246
Gnomad MID
AF:
0.285
Gnomad NFE
AF:
0.170
Gnomad OTH
AF:
0.260
GnomAD2 exomes
AF:
0.251
AC:
62889
AN:
250832
AF XY:
0.240
show subpopulations
Gnomad AFR exome
AF:
0.448
Gnomad AMR exome
AF:
0.416
Gnomad ASJ exome
AF:
0.218
Gnomad EAS exome
AF:
0.311
Gnomad FIN exome
AF:
0.233
Gnomad NFE exome
AF:
0.169
Gnomad OTH exome
AF:
0.217
GnomAD4 exome
AF:
0.194
AC:
283768
AN:
1461000
Hom.:
31549
Cov.:
34
AF XY:
0.194
AC XY:
141175
AN XY:
726836
show subpopulations
African (AFR)
AF:
0.454
AC:
15194
AN:
33452
American (AMR)
AF:
0.398
AC:
17798
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.225
AC:
5868
AN:
26130
East Asian (EAS)
AF:
0.366
AC:
14537
AN:
39694
South Asian (SAS)
AF:
0.257
AC:
22140
AN:
86244
European-Finnish (FIN)
AF:
0.231
AC:
12327
AN:
53284
Middle Eastern (MID)
AF:
0.239
AC:
1376
AN:
5764
European-Non Finnish (NFE)
AF:
0.164
AC:
182079
AN:
1111368
Other (OTH)
AF:
0.206
AC:
12449
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
11291
22582
33873
45164
56455
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6904
13808
20712
27616
34520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.274
AC:
41673
AN:
152044
Hom.:
6866
Cov.:
32
AF XY:
0.278
AC XY:
20647
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.447
AC:
18527
AN:
41448
American (AMR)
AF:
0.303
AC:
4622
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.215
AC:
744
AN:
3468
East Asian (EAS)
AF:
0.324
AC:
1673
AN:
5164
South Asian (SAS)
AF:
0.251
AC:
1210
AN:
4816
European-Finnish (FIN)
AF:
0.246
AC:
2596
AN:
10568
Middle Eastern (MID)
AF:
0.303
AC:
89
AN:
294
European-Non Finnish (NFE)
AF:
0.170
AC:
11584
AN:
67988
Other (OTH)
AF:
0.262
AC:
553
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1456
2912
4367
5823
7279
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
398
796
1194
1592
1990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.205
Hom.:
13583
Bravo
AF:
0.288
Asia WGS
AF:
0.294
AC:
1020
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Protoporphyria, erythropoietic, 1 Pathogenic:1Uncertain:1Benign:4
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 08, 2021
Institute of Human Genetics, University Hospital Muenster
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ACMG categories: PS5,BS2,BP6,BP7 -

Jan 01, 1992
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Jan 01, 2016
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was classified as: Likely benign. -

Apr 22, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 8280787, 1729699, 27884173, 26789144) -

not specified Benign:1
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jaundice;C0041834:Erythema Benign:1
Jan 25, 2016
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
6.0
DANN
Benign
0.51
PhyloP100
0.51
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2269219; hg19: chr18-55247454; COSMIC: COSV50490971; API